Manufacturer record
Zenith Drugs Ltd. 72/5 & 72/3: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Zenith Drugs Ltd. 72/5 & 72/3 (Madhya Pradesh) were declared Not of Standard Quality between June 2026 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Zenith Drugs Ltd. 72/5 & 72/3 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Tablets IP 650mg | T60095Mfg 2026-03 · Exp 2028-02 | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL,GuwahatiState lab | Jul 2026 |
| AZITHROMYCIN ORAL SUSPENSION IP 200 MG/5ML | 41410Mfg 2024-10 · Exp 2026-09 | 1. The content of azithromycin in the sample is less(i.e. 65.76% of the labelled amount than the i.p. Limits. 2.Tthe sample is infested with fungus growth. all the observations are done in normal daylight conditions with unaided eyes.4xl5 ml intact brown coloured plastic bottles received for analysis. When opens for analysis, it is observed that in all these 4X15 ML bottles particles are stick around the neck of the bottle. During analysis when the content from these 4x15 ml bottles after shaking transferred individually in clean dry sterilised glass beaker, contains yellow coloured suspension. Yellow coloured suspension which mixes uniformly after shaking.Labelling | FDAL, MumbaiState lab | Jul 2026 |
| Paracetamol Paediatric Oral suspension IP | L5DD15Mfg 2025-01 · Exp 2026-12 | The sample does not comply with IP requirement for related substances test. The sample does notshow identification test for colour carmoisine, Hence the sample is misbranded vide rule 96 and section 17(b) and 17 ( c) of Drugs and Cosmetics Act 1940 and Rules thereunderIdentification | FDAL, MumbaiState lab | Jun 2026 |
| Paracetamol Paediatric Oral suspension IP | LB5172Mfg 2025-10 · Exp 2027-09 | The sample does not comply with IP requirement for related substances.Related substances | FDAL, MumbaiState lab | Jun 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.